<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>13</Volume><Issue>3</Issue><PubDate PubStatus="epublish"><Year>2022</Year><Month>04</Month><Day>10</Day></PubDate></Journal><title locale="en_US">New COVID‑19 Vaccine: What about Cost and Utility?</title><FirstPage>2635</FirstPage><LastPage>2635</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Private Academic Consultant, Bangkok</affiliation></Author><Author><affiliation locale="en_US">Honorary professor, Dr DY Patil University, Pune, Maharashtra, India; Adjunct Professor, Joseph Ayobabalola University, Ikeiji‑Arakeji</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2022</Year><Month>04</Month><Day>10</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;Coronavirus disease 2019 (COVID‑19) already causes health problems in more than 50,000,000 people around the world. The effective way to prevention of this emerging coronavirus disease is vaccination.[1] Recently (November 2020), many pharmaceutical manufacturers declared for success in COVID‑19 vaccine developments. There are also reports on efficacy of the vaccine and proposed price of the vaccination. As a new vaccination, the important consideration is on vaccine affordability and accessibility.&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2635</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2635/717718476</pdf_url></Article></Articles>
